Savitz Ryan
CIK 1992324
Transactions on file
29
Tickers traded
Recent activity
| Filed | Txn date | Issuer | Roles | Code | Shares | Value | % since Filing | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-11-12 | 2026-11-12 | DNTH Dianthus Therapeutics, Inc. /DE/ | EVP, CFO & CBO | Sale | 17,724 | $1.61M | -4.0% | open → |
| 2026-11-12 | 2026-11-12 | DNTH Dianthus Therapeutics, Inc. /DE/ | EVP, CFO & CBO | Exer. | 16,385 | $361.6K | +294.1% | open → |
| 2026-11-12 | 2026-11-12 | DNTH Dianthus Therapeutics, Inc. /DE/ | EVP, CFO & CBO | Exer. | 1,339 | $29.2K | +299.5% | open → |
| 2026-11-12 | 2026-11-11 | DNTH Dianthus Therapeutics, Inc. /DE/ | EVP, CFO & CBO | Sale | 3,044 | $274.1K | -3.4% | open → |
| 2026-11-12 | 2026-11-11 | DNTH Dianthus Therapeutics, Inc. /DE/ | EVP, CFO & CBO | Exer. | 1,300 | $28.7K | +294.1% | open → |
| 2026-11-12 | 2026-11-11 | DNTH Dianthus Therapeutics, Inc. /DE/ | EVP, CFO & CBO | Exer. | 1,744 | $38.0K | +299.5% | open → |
| 2026-11-12 | 2026-11-10 | DNTH Dianthus Therapeutics, Inc. /DE/ | EVP, CFO & CBO | Sale | 2,561 | $230.8K | -3.5% | open → |
| 2026-11-12 | 2026-11-10 | DNTH Dianthus Therapeutics, Inc. /DE/ | EVP, CFO & CBO | Exer. | 1,260 | $27.8K | +294.1% | open → |
| 2026-11-12 | 2026-11-10 | DNTH Dianthus Therapeutics, Inc. /DE/ | EVP, CFO & CBO | Exer. | 1,301 | $28.3K | +299.5% | open → |
| 2026-11-12 | 2026-11-09 | DNTH Dianthus Therapeutics, Inc. /DE/ | EVP, CFO & CBO | Sale | 2,064 | $189.0K | -5.0% | open → |
| 2026-11-12 | 2026-11-09 | DNTH Dianthus Therapeutics, Inc. /DE/ | EVP, CFO & CBO | Sale | 58,396 | $5.31M | -4.3% | open → |
| 2026-11-12 | 2026-11-09 | DNTH Dianthus Therapeutics, Inc. /DE/ | EVP, CFO & CBO | Sale | 37,517 | $3.38M | -3.5% | open → |
| 2026-11-12 | 2026-11-09 | DNTH Dianthus Therapeutics, Inc. /DE/ | EVP, CFO & CBO | Sale | 1,736 | $154.2K | -2.1% | open → |
| 2026-11-12 | 2026-11-09 | DNTH Dianthus Therapeutics, Inc. /DE/ | EVP, CFO & CBO | Sale | 700 | $60.7K | +0.3% | open → |
| 2026-11-12 | 2026-11-09 | DNTH Dianthus Therapeutics, Inc. /DE/ | EVP, CFO & CBO | Sale | 300 | $25.5K | +2.1% | open → |
| 2026-11-12 | 2026-11-09 | DNTH Dianthus Therapeutics, Inc. /DE/ | EVP, CFO & CBO | Exer. | 10,399 | $87.8K | +930.6% | open → |
| 2026-11-12 | 2026-11-09 | DNTH Dianthus Therapeutics, Inc. /DE/ | EVP, CFO & CBO | Exer. | 40,430 | $892.3K | +294.1% | open → |
| 2026-11-12 | 2026-11-09 | DNTH Dianthus Therapeutics, Inc. /DE/ | EVP, CFO & CBO | Exer. | 20,608 | $448.6K | +299.5% | open → |
| 2026-11-12 | 2026-11-09 | DNTH Dianthus Therapeutics, Inc. /DE/ | EVP, CFO & CBO | Exer. | 29,276 | $523.5K | +386.5% | open → |
| 2026-07-13 | 2026-07-09 | DNTH Dianthus Therapeutics, Inc. /DE/ | EVP, CFO & CBO | Sale | 5,566 | $567.6K | -14.7% | open → |
| 2026-07-13 | 2026-07-09 | DNTH Dianthus Therapeutics, Inc. /DE/ | EVP, CFO & CBO | Sale | 15,329 | $1.55M | -14.1% | open → |
| 2026-07-13 | 2026-07-09 | DNTH Dianthus Therapeutics, Inc. /DE/ | EVP, CFO & CBO | Sale | 10,354 | $1.04M | -13.2% | open → |
| 2026-07-13 | 2026-07-09 | DNTH Dianthus Therapeutics, Inc. /DE/ | EVP, CFO & CBO | Exer. | 31,249 | $680.3K | +299.5% | open → |
| 2026-04-10 | 2026-04-09 | DNTH Dianthus Therapeutics, Inc. /DE/ | EVP, CFO & CBO | Sale | 8,224 | $738.8K | -3.2% | open → |
| 2026-04-10 | 2026-04-09 | DNTH Dianthus Therapeutics, Inc. /DE/ | EVP, CFO & CBO | Exer. | 8,224 | $147.0K | +386.5% | open → |
| 2025-12-05 | 2025-12-04 | DNTH Dianthus Therapeutics, Inc. /DE/ | CFO & CBO | Sale | 20,000 | $903.6K | +92.5% | open → |
| 2025-12-05 | 2025-12-04 | DNTH Dianthus Therapeutics, Inc. /DE/ | CFO & CBO | Exer. | 20,000 | $168.8K | +930.6% | open → |
| 2025-09-11 | 2025-09-09 | DNTH Dianthus Therapeutics, Inc. /DE/ | Officer CFO & CBO | Exer. | 20,000 | $168.8K | +930.6% | open → |
| 2025-09-11 | 2025-09-09 | DNTH Dianthus Therapeutics, Inc. /DE/ | Officer CFO & CBO | Sale | 20,000 | $700.0K | +148.5% | open → |